Wednesday, September 25, 2019

GSK Pharma recalls ranitidine hydrochloride products from all markets

The Company manufactures Ranitidine Hydrochloride IP Tablets 150 mg and 300 mg (Zinetac) using API from Saraca Laboratories Limited and another supplier, SMS Lifesciences India Limited, for supply to Indian market.

from India Infoline News Service https://ift.tt/2nkVTE1

No comments:

Post a Comment